Department of Anesthesia, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA; Department of Anesthesia, Kameda General Hospital, Chiba, Japan.
Department of Anesthesiology, University of Illinois-Chicago, Chicago, IL.
J Cardiothorac Vasc Anesth. 2021 Jan;35(1):73-80. doi: 10.1053/j.jvca.2020.08.040. Epub 2020 Aug 22.
Patients chronically treated with angiotensin-converting enzyme inhibitors (ACEIs) may develop hypotension after induction of general anesthesia. A fraction of these patients are resistant to therapeutic doses of vasopressors, which poses serious concerns for hemodynamic management. The authors hypothesized that the patients who develop refractory hypotension, compared with those who do not, show lower central arterial stiffness due to the profound effect of ACEIs.
Prospective observational study.
Single tertiary center.
Fifty surgical patients chronically treated with ACEIs were enrolled. Prior to surgery, all the patients had central arterial stiffness assessment measured by carotid-femoral pulse-wave velocity. Patients were categorized into 2 groups according to the systolic blood pressure response during the first 10 minutes after induction of general anesthesia: a vasopressor-resistant hypotension group requiring more than 200 µg phenylephrine, or a control group requiring no more than 200 µg of phenylephrine to maintain systolic blood pressure above 90 mmHg during the study period.
Carotid-femoral pulse-wave velocity was significantly lower in the vasopressor-resistant hypotension group compared to the control group (7.6 [7.2-8.3] m/s v 9.9 [8.7-12.0] m/s, p = 0.001 [Hodges-Lehman median difference 2.2, 95% confidence interval = 1.1-4.4]).
These findings suggested that preoperative measurement of carotid-femoral pulse-wave velocity in patients chronically treated with ACEIs could help identify patients at increased risk of developing hypotension refractory to vasopressors after induction of general anesthesia.
接受血管紧张素转换酶抑制剂(ACEI)长期治疗的患者在全身麻醉诱导后可能会出现低血压。其中一部分患者对血管加压药的治疗剂量有抵抗作用,这给血流动力学管理带来了严重问题。作者假设,与未发生低血压的患者相比,发生难治性低血压的患者由于 ACEI 的深远影响,其中心动脉僵硬程度较低。
前瞻性观察性研究。
单一的三级中心。
纳入了 50 名接受 ACEI 长期治疗的手术患者。在手术前,所有患者均接受了颈动脉-股动脉脉搏波速度的中心动脉僵硬评估。根据全身麻醉诱导后 10 分钟内的收缩压反应,将患者分为 2 组:需要超过 200µg 去氧肾上腺素的血管加压素抵抗性低血压组,或在研究期间需要不超过 200µg 去氧肾上腺素即可维持收缩压高于 90mmHg 的对照组。
与对照组相比,血管加压素抵抗性低血压组的颈动脉-股动脉脉搏波速度明显较低(7.6[7.2-8.3]m/s比 9.9[8.7-12.0]m/s,p=0.001[Hodges-Lehman 中位数差异 2.2,95%置信区间为 1.1-4.4])。
这些发现表明,在接受 ACEI 长期治疗的患者中,术前测量颈动脉-股动脉脉搏波速度可能有助于识别在全身麻醉诱导后发生血管加压素抵抗性低血压风险增加的患者。